A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07662109

Title field or adapter rule

{'original_value': 'A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.313587+00:00

Published At

2026-10-30T00:00:00+00:00

Record Updated At

2026-10-30

Source Retrieved At

2026-10-31T22:18:45.365006+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Type 2 Diabetes Mellitus"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-30", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07662109"

protocolSection.identificationModule.officialTitle

"A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Type 2 Diabetes Mellitus (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Elecoglipron dose level 1 + dapagliflozin', 'Elecoglipron dose level 1 + dapagliflozin-matched placebo', 'Elecoglipron dose level 2 + dapagliflozin', 'Elecoglipron dose level 2 + dapagliflozin-matched placebo'], 'description': 'Elecoglipron is administered orally once daily.', 'name': 'Elecoglipron', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Elecoglipron dose level 1 + dapagliflozin', 'Elecoglipron dose level 2 + dapagliflozin', 'Elecoglipron-matched placebo + dapagliflozin'], 'description': 'Dapagliflozin administered orally once daily.', 'name': 'Dapagliflozin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Elecoglipron-matched placebo + dapagliflozin'], 'description': 'A placebo matching elecoglipron administered orally once daily.', 'name': 'Elecoglipron-matched placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Elecoglipron dose level 1 + dapagliflozin-matched placebo', 'Elecoglipron dose level 2 + dapagliflozin-matched placebo'], 'description': 'A placebo matching dapagliflozin administered orally once daily.', 'name': 'Dapagliflozin-matched placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Elecoglipron (protocolSection.armsInterventionsModule.interventions[].name)
• Dapagliflozin (protocolSection.armsInterventionsModule.interventions[].name)
• Elecoglipron-matched placebo (protocolSection.armsInterventionsModule.interventions[].name)
• Dapagliflozin-matched placebo (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.